The genome of murine cytomegalovirus is shaped by purifying selection and extensive recombination

Virology

Volumn 435, Issue 2, 2013, Pages 258-268

  Smith, L M ^a   McWhorter, A R ^a   Shellam, G R ^a   Redwood, A J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Codon based selection; Murine cytomegalovirus; Recombination; Viral genome

Indexed keywords

NUCLEOTIDE;

AMINO ACID SUBSTITUTION; ARTICLE; BETAHERPESVIRINAE; CODON; CYTOMEGALOVIRUS; GENE SEQUENCE; GENETIC CONSERVATION; MOLECULAR EVOLUTION; MOUSE; MURINE CYTOMEGALOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; PURIFYING SELECTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; VIRUS GENOME; VIRUS ISOLATION; VIRUS PURIFICATION; VIRUS RECOMBINATION; VIRUS STRAIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CODON; GENOME, VIRAL; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MUROMEGALOVIRUS; OPEN READING FRAMES; RECOMBINATION, GENETIC; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA;

HERPESVIRIDAE; MAIZE CHLOROTIC MOTTLE VIRUS; MURID HERPESVIRUS 1; MUS;

EID: 84871699431     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.08.041     Document Type: Article

References (95)

1. Abendroth A., Lin I., Slobedman B., Ploegh H., Arvin A.M. Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells. J. Virol. 2001, 75:4878-4888.
2. Achour A., Malet I., Le Gal F., Dehee A., Gautheret-Dejean A., Bonnafous P., Agut H. Variability of gB and gH genes of human herpesvirus-6 among clinical specimens. J. Med. Virol. 2008, 80:1211-1221.
3. Araullo-Cruz T.P. Humoral and cell-mediated immunity in murine cytomegalovirus infection. Diss. Abstr. Int. 1979, 39B:37-49.
4. Arens R., Wang P., Sidney J., Loewendorf A., Sette A., Schoenberger S.P., Peters B., Benedict C.A. Murine cytomegalovirus induces a polyfunctional CD4 T cell response. J. Immunol. 2008, 180:6472-6476.
5. Bar M., Shannon-Lowe C., Geballe A.P. Differentiation of human cytomegalovirus genotypes in immunocompromised patients on the basis of UL4 gene polymorphisms. J. Infect. Dis. 2001, 183:218-225.
6. Booth T.W., Scalzo A.A., Carrello C., Lyons P.A., Farrell H.E., Singleton G.R., Shellam G.R. Molecular and biological characterization of new strains of murine cytomegalovirus isolated from wild mice. Arch. Virol. 1993, 132:209-220.
7. Borrow P., Lewicki H., Wei X., Horwitz M.S., Peffer N., Meyers H., Nelson J.A., Gairin J.E., Hahn B.H., Oldstone M.B., Shaw G.M. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 1997, 3:205-211.
8. Bradley A.J., Lurain N.S., Ghazal P., Trivedi U., Cunningham C., Baluchova K., Gatherer D., Wilkinson G.W.G., Dargan D.J., Davison A.J. High-throughput sequence analysis of variants of human cytomegalovirus strains Towne and AD169. J. Gen. Virol. 2009, 90:2375-2380.
9. Brocchieri L., Kledal T.N., Karlin S., Mocarski E.S. Predicting coding potential from genome sequence: application to betaherpesviruses infecting rats and mice. J. Virol. 2005, 79:7570-7596.
10. Brown S.M., Subak-Sharpe J.H., Harland J., Maclean A.R. Analysis of intrastrain recombination in herpes simplex virus type 1 strain 17 and herpes simplex virus type 2 strain HG52 using restriction endonuclease sites as unselected markers and temperature-sensitive lesions as selected markers. J. Gen. Virol. 1992, 73:293-301.
11. Bubic I., Wagner M., Krmpotic A., Saulig T., Kim S., Yokoyama W.M., Jonjic S., Koszinowski U.H. Gain of virulence caused by loss of a gene in murine cytomegalovirus. J. Virol. 2004, 78:7536-7544.
12. Cheng T.P., Valentine M.C., Gao J., Pingel J.T., Yokoyama W.M. Stability of murine cytomegalovirus genome after in vitro and in vivo passage. J. Virol. 2010, 84:2623-2628.
13. Chou S.W. Reactivation and recombination of multiple cytomegalovirus strains from individual organ donors. J. Infect. Dis. 1989, 160:11-15.
14. Corbett A., Coudert J., Forbes C., Scalzo A. Functional consequences of natural sequence variation of murine cytomegalovirus m157 for Ly49 receptor specificity and NK cell activation. J. Immunol. 2010, 186:1713-1722.
15. Corbett A.J., Forbes C.A., Moro D., Scalzo A.A. Extensive sequence variation exists among isolates of murine cytomegalovirus within members of the m02 family of genes. J. Gen. Virol. 2007, 88:758-769.
16. Cumpston, J.S., 1968. Macquarie Island. In Science Report Series A 93 (ANARE), pp. 1-380.
17. Cunningham C., Gatherer D., Hilfrich B., Baluchova K., Dargan D.J., Thomson M., Griffiths P.D., Wilkinson G.W.G., Schulz T.F., Davison A.J. Sequences of complete human cytomegalovirus genomes from infected cell cultures and clinical specimens. J. Gen. Virol. 2010, 91:605-615.
18. Dargan D.J., Douglas E., Cunningham C., Jamieson F., Stanton R.J., Baluchova K., McSharry B.P., Tomasec P.T., Emery V.C., Percivalle E., Sarasini A., Gerna G., Wilkinson G.W.G., Davison A.J. Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture. J. Gen. Virol. 2010, 91:1535-1546.
19. de Campos-Lima P.O., Gavioli R., Zhang Q.J., Wallace L.E., Dolcetti R., Rowe M., Rickinson A.B., Masucci M.G. HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. Science 1993, 260:98-100.
20. de Campos-Lima P.O., Levitsky V., Brooks J., Lee S.P., Hu L.F., Rickinson A.B., Masucci M.G. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. J. Exp. Med. 1994, 179:1297-1305.
21. Dohner D.E., Adams S.G., Gelb L.D. Recombination in tissue culture between varicella-zoster virus strains. J. Med. Virol. 1988, 24:329-341.
22. Faure-Della Corte M., Samot J., Garrigue I., Magnin N., Reigadas S., Couzi L., Dromer C., Velly J.-F., Dechanet-Merville J., Fleury H.J.A., Lafon M.-E. Variability and recombination of clinical human cytomegalovirus strains from transplantation recipients. J. Clin. Virol. 2010, 47:161-169.
23. Froissart R., Roze D., Uzest M., Galibert L., Blanc S., Michalakis Y. Recombination every day: abundant recombination in a virus during a single multi-cellular host infection. PLoS Biol. 2005, 3:e89.
24. Fujita K., Maeda K., Yokoyama N., Miyazawa T., Kai C., Mikami T. In vitro recombination of feline herpesvirus type 1. Arch. Virol. 1998, 143:25-34.
25. Gabriel S.I., Stevens M.I., de Luz Mathias M., Searle J.B. 'Of mice and 'convicts': origin of the Australian house mouse, Mus musculus. Plos One 2011, 6:e28622.
26. Garrigue I., Corte M.F.-D., Magnin N., Couzi L., Capdepont S., Rio C., Merville P., Dechanet-Merville J., Fleury H., Lafon M.-E. Variability of UL18, UL40, UL111a and US3 immunomodulatory genes among human cytomegalovirus clinical isolates from renal transplant recipients. J. Clin. Virol. 2007, 40:120-128.
27. Glosson N.L., Hudson A.W. Human herpesvirus-6A and -6B encode viral immunoevasins that downregulate class I MHC molecules. Virology 2007, 365:125-135.
28. Gold M.C., Munks M.W., Wagner M., Koszinowski U.H., Hill A.B., Fling S.P. The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo. J. Immunol. 2002, 169:359-365.
29. Gorman S., Harvey N.L., Moro D., Lloyd M.L., Voigt V., Smith L.M., Lawson M.A., Shellam G.R. Mixed infection with multiple strains of murine cytomegalovirus occurs following simultaneous or sequential infection of immunocompetent mice. J. Gen. Virol. 2006, 87:1123-1132.
30. Gorzer I., Guelly C., Trajanoski S., Puchhammer-Stockl E. Deep sequencing reveals highly complex dynamics of human cytomegalovirus genotypes in transplant patients over time. J. Virol. 2010, 84:7195-7203.
31. Gorzer I., Kerschner H., Jaksch P., Bauer C., Seebacher G., Klepetko W., Puchhammer-Stockl E. Virus load dynamics of individual CMV-genotypes in lung transplant recipients with mixed-genotype infections. J. Med. Virol. 2008, 80:1405-1414.
32. Goulder P.J.R., Brander C., Tang Y., Tremblay C., Colbert R.A., Addo M.M., Rosenberg E.S., Nguyen T., Allen R., Trocha A., Altfeld M., He S., Bunce M., Funkhouser R., Pelton S.I., Burchett S.K., McIntosh K., Korber B.T.M., Walker B.D. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 2001, 412:334-338.
33. Grosjean J., Hantz S., Cotin S., Baclet M.C., Mengelle C., Trapes L., Virey B., Undreiner F., Brosset P., Pasquier C., Denis F., Alain S. Direct genotyping of cytomegalovirus envelope glycoproteins from toddler's saliva samples. J. Clin. Virol. 2009, 46:S43-S48.
34. Haberland M., Meyer-Konig U., Hufert F.T. Variation within the glycoprotein B gene of human cytomegalovirus is due to homologous recombination. J. Gen. Virol. 1999, 80:1495-1500.
35. Hassink G.C., Duijvestijn-Van Dam J.G., Koppers-Lalic D., Van Gaans-Van den Brik J., Van Leeuwen D., Vink C., Bruggeman C.A., Wiertz E. Rat cytomegalovirus induces a temporal downregulation of major histocompatibility complex class I cell surface expression. Viral Immunol. 2005, 18:607-615.
36. Heo J., Petheram S., Demmler G., Murph J.R., Adler S.P., Bale J., Sparer T.E. Polymorphisms within human cytomegalovirus chemokine (UL146/UL147) and cytokine receptor genes (UL144) are not predictive of sequelae in congenitally infected children. Virology 2008, 378:86-96.
37. Holtappels R., Grzimek N.K., Simon C.O., Thomas D., Dreis D., Reddehase M.J. Processing and presentation of murine cytomegalovirus pORFm164-derived peptide in fibroblasts in the face of all viral immunosubversive early gene functions. J. Virol. 2002, 76:6044-6053.
38. Holtappels R., Grzimek N.K., Thomas D., Reddehase M.J. Early gene m18, a novel player in the immune response to murine cytomegalovirus. J. Gen. Virol. 2002, 83:311-316.
39. Holtappels R., Thomas D., Podlech J., Reddehase M.J. Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2(d) haplotype. J. Virol. 2002, 76:151-164.
40. Holtappels R., Thomas D., Reddehase M.J. Identification of a K-d-restricted antigenic peptide encoded by murine cytomegalovirus early gene M84. J. Gen. Virol. 2000, 81:3037-3042.
41. Huson D.H., Bryant D. Application of phylogenetic networks in evolutionary studies. Mol. Biol. Evol. 2006, 23:254-267.
42. Ishido S., Wang C.Y., Lee B.S., Cohen G.B., Jung J.U. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J. Virol. 2000, 74:5300-5309.
43. Javier R.T., Sedarati F., Stevens J.G. Two avirulent herpes simplex viruses generate lethal recombinants in vivo. Science 1986, 234:746-748.
44. Jonjic S., Mutter W., Weiland F., Reddehase M.J., Koszinowski U.H. Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ lymphocytes. J. Exp. Med. 1989, 169:1199-1212.
45. Jonjic S., Pavic I., Polic B., Crnkovic I., Lucin P., Koszinowski U.H. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J. Exp. Med. 1994, 179:1713-1717.
46. Jordan S., Krause J., Prager A., Mitrovic M., Jonjic S., Koszinowski U.H., Adler B. Virus Progeny of murine cytomegalovirus bacterial artificial chromosome pSM3fr show reduced growth in salivary glands due to a fixed mutation of MCK-2. J. Virol. 2011, 85:10346-10353.
47. Klenovsek K., Weisel F., Schneider A., Appelt U., Jonjic S., Messerle M., Bradel-Tretheway B., Winkler T.H., Mach M. Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells. Blood 2007, 110:3472-3479.
48. Korber, B., 2000. HIV signature and sequence variation analysis, In: Rodrigo, A.G., Learn, G.H., (Eds.), Computational Analysis of HIV Molecular Sequences, Kluwer Academic, Dodrecht, The Netherlands. pp. 55-72. (Chapter 4).
49. Kosakovsky Pond S.L., Frost S.D.W. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol. Biol. Evol. 2005, 22:1208-1222.
50. Kosakovsky Pond S.L., Posada D., Gravenor M.B., Woelk C.H., Frost S.D.W. Automated phylogenetic detection of recombination using a genetic algorithm. Mol. Biol. Evol. 2006, 23:1891-1901.
51. Krmpotic A., Busch D.H., Bubic I., Gebhardt F., Hengel H., Hasan M., Scalzo A.A., Koszinowski U.H., Jonjic S. MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat. Immunol. 2002, 3:529-535.
52. Kidder J.H. The natural history of Kerguelen Island. Am. Nat. 1876, 10:481-484.
53. Lefeuvre P., Lett J.M., Varsani A., Martin D.P. Widely conserved recombination patterns among single-stranded DNA viruses. J. Virol. 2009, 83:2697-2707.
54. Lyons P.A., Allan J.E., Carrello C., Shellam G.R., Scalzo A.A. Effect of natural sequence variation at the H-2Ld-restricted CD8+ T cell epitope of the murine cytomegalovirus ie1-encoded pp89 on T cell recognition. J. Gen. Virol. 1996, 77:2615-2623.
55. Manning W.C., Mocarski E.S. Insertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene (ie2) is dispensable for growth. Virology 1988, 167:477-484.
56. Martin D.P., Lemey P., Lott M., Moulton V., Posada D., Lefeuvre P. RDP3: a flexible and fast computer program for analyzing recombination. Bioinformatics 2010, 26:2462-2463.
57. Meurens F., Keil G.M., Muylkens B., Gogev S., Schynts F., Negro S., Wiggers L., Thiry E. Interspecific recombination between two ruminant alphaherpesviruses, bovine herpesviruses 1 and 5. J. Virol. 2004, 78:9828-9836.
58. Midgley R.S., Blake N.W., Yao Q.Y., Croom-Carter D., Cheung S.T., Leung S.F., Chan A.T.C., Johnson P.J., Huang D., Rickinson A.B., Lee S.P. Novel intertypic recombinants of Epstein-Barr virus in the Chinese population. J. Virol. 2000, 74:1544-1548.
59. Mild M., Esbjornsson J., Fenyo E.M., Medstrand P. Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch. J. Virol. 2007, 81:3369-3376.
60. Monci F., Sánchez-Campos S., Navas-Castillo J., Moriones E. A natural recombinant between the geminiviruses tomato yellow leaf curl sardinia virus and tomato yellow leaf curl virus exhibits a novel pathogenic phenotype and is becoming prevalent in Spanish populations. Virology 2002, 303:317-326.
61. Moutouh L., Corbeil J., Richman D.D. Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure. Proc. Nat. Acad. Sci. USA 1996, 93:6106-6111.
62. Munks M.W., Gold M.C., Zajac A.L., Doom C.M., Morello C.S., Spector D.H., Hill A.B. Genome-wide analysis reveals a highly diverse CD8 T cell response to murine cytomegalovirus. J. Immunol. 2006, 176:3760-3766.
63. Murphy, G.R., Williams, H.R., Hide, G., 2005. Population Biology of the Urban Mouse (Mus Domesticus) in the UK. In: Lee, Chow-Yang, Robinson, William H., (Eds). Proceedings of the Fifth International Conference on Urban Pests. Malaysia, pp 351-355.
64. Muylkens B., Farnir F., Meurens F., Schynts F., Vanderplasschen A., Georges A., Thiry E. Coinfection with two closely related alphaherpesviruses results in a highly diversified recombination mosaic displaying negative genetic interference. J. Virol. 2009, 83:3127-3137.
65. Nora T., Charpentier C., Tenaillon O., Hoede C., Clavel F., Hance A.J. Contribution of recombination to the evolution of human immunodeficiency viruses expressing resistance to antiretroviral treatment. J. Virol. 2007, 81:7620-7628.
66. Norberg P., Kasubi M.J., Haarr L., Bergstrom T., Liljeqvist J.-A. Divergence and recombination of clinical herpes simplex virus type 2 isolates. J. Virol. 2007, 81:13158-13167.
67. Norberg P., Tyler S., Severini A., Whitley R., Liljeqvist J.-Å., et al. A genome-wide comparative evolutionary analysis of herpes simplex virus type 1 and varicella zoster virus. PLoS One 2011, 6:e22527. 10.1371/journal.pone.0022527.
68. Noriega V.M., Tortorella D. Human cytomegalovirus-encoded immune modulators partner to downregulate major histocompatibility complex class I molecules. J. Virol. 2009, 83:1359-1367.
69. Numazaki K., Ikehata M., Asanuma H., Chiba S. Simultaneous infection of immunocompetent individuals with multiple cytomegalovirus strains. Lancet 1998, 352:1710.
70. Osborn, J. E. 1982. Cytomegalovirus and other herpesviruses.In: Foster, H. L., Small, J. D., Fox, J. G. (Eds.), The Mouse in Biomedical Research. vol. II: Diseases, Academic Press, New York. pp. 267-292.
71. Rawlinson W.D., Farrell H.E., Barrell B.G. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 1996, 70:8833-8849.
72. Reddehase M.J., Fibi M.R., Keil G.M., Koszinowski U.H. Late-phase expression of a murine cytomegalovirus immediate-early antigen recognized by cytolytic T lymphocytes. J. Virol. 1986, 60:1125-1129.
73. Reddehase M.J., Rothbard J.B., Koszinowski U.H. A pentapeptide as minimal antigenic determinant for Mhc class-I-restricted lymphocytes-T. Nature 1989, 337:651-653.
74. Renzette N., Bhattacharjee B., Jensen J.D., Gibson L., Kowalik T.F. Extensive genome-wide variability of human cytomegalovirus in congenitally infected infants. PLoS Pathog. 2011, 7:e1001344.
75. Ross S.A., Novak Z., Pati S., Patro R.K., Blumenthal J., Danthuluri V.R., Ahmed A., Michaels M.G., Sãnchez P.J., Bernstein D.I., Tolan R.W., Palmer A.L., Britt W.J., Fowler K.B., Boppana S.B. Mixed infection and strain diversity in congenital cytomegalovirus infection. J. Infect. Dis. 2011, 204(7):1003-1007.
76. Schynts F., Meurens F., Detry B., Vanderplasschen A., Thiry E. Rise and survival of bovine herpesvirus 1 recombinants after primary infection and reactivation from latency. J. Virol. 2003, 77:12535-12542.
77. Schynts F., Vanderplasschen A., Hanon E., Rijsewijk F.A., van Oirschot J.T., Thiry E. Use of PCR and immunofluorescence to detect bovine herpesvirus 1 recombinants. J. Virol. Methods 2001, 92:99-104.
78. Simon C.O., Holtappels R., Tervo H.M., Bohm V., Daubner T., Oehrlein-Karpi S.A., Kuhnapfel B., Renzaho A., Strand D., Podlech J., Reddehase M.J., Grzimek N.K. CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation. J. Virol. 2006, 80:10436-10456.
79. Smith L.M., McWhorter A.R., Masters L.L., Shellam G.R., Redwood A.J. Laboratory strains of murine cytomegalovirus are genetically similar to but phenotypically distinct from wild strains of virus. J. Virol. 2008, 82:6689-6696.
80. Smith L.M., Shellam G.R., Redwood A.J. Genes of murine cytomegalovirus exist as a number of distinct genotypes. Virology 2006, 352:450-465.
81. Smith M.G. Propagation of salivary gland virus of mouse in tissue cultures. Proc. Soc. Exp. Biol. Med. 1954, 86:435-440.
82. Steininger C. Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system. Clin. Microbiol. Infect. 2007, 13:953-963.
83. Steininger C., Schmied B., Sarcletti M., Geit M., Puchhammer-Stockl E. Cytomegalovirus genotypes present in cerebrospinal fluid of HIV-infected patients. Aids 2005, 19:273-278.
84. Steinway S., Dannenfelser R., Laucius C., Hayes J., Nayak S. JCoDA: a tool for detecting evolutionary selection. BMC Bioinf. 2010, 11:284.
85. Tang Q., Murphy E.A., Maul G.G. Experimental confirmation of global murine cytomegalovirus open reading frames by transcriptional detection and partial characterization of newly described gene products. J. Virol. 2006, 80(14):6873-6882.
86. Timoshenko O., Al-Ali A., Martin B.A., Sweet C. Identification of mutations in a temperature sensitive mutant (tsm5) of murine cytomegalovirus using complementary genome sequencing. J. Med. Virol. 2009, 81(3):511-518.
87. Urbanowicz A., Alejska M., Formanowicz P., Blazewicz J., Figlerowicz M., Bujarski J.J. Homologous crossovers among molecules of brome mosaic bromovirus RNA1 or RNA2 segments in vivo. J. Virol. 2005, 79(9):5732-5742.
88. Voigt V., Forbes C.A., Tonkin J.N., Degli-Esposti M.A., Smith H.R., Yokoyama W.M., Scalzo A.A. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc. Nat. Acad. Sci. USA 2003, 100:13483-13488.
89. Wain-Hobson S., Renoux-Elbe C.l., Vartanian J.-P., Meyerhans A. Network analysis of human and simian immunodeficiency virus sequence sets reveals massive recombination resulting in shorter pathways. J. Gen. Virol. 2003, 84:885-895.
90. Walling D.M., Clark N.M., Markovitz D.M., Frank T.S., Braun D.K., Eisenberg E., Krutchkoff D.J., Felix D.H., Raab-Traub N. Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia. J. Infect. Dis. 1995, 171:1122-1130.
91. Walton S.M., Wyrsch P., Munks M.W., Zimmermann A., Hengel H., Hill A.B., Oxenius A. The dynamics of mouse cytomegalovirus-specific CD4 T cell responses during acute and latent infection. J. Immunol. 2008, 181:1128-1134.
92. Weiner A., Erickson A.L., Kansopon J., Crawford K., Muchmore E., Hughes A.L., Houghton M., Walker C.M. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc. Nat. Acad. Sci. USA 1995, 92:2755-2759.
93. Wieland S.F., Chisari F.V. Stealth and cunning: Hepatitis B and Hepatitis C viruses. J. Virol. 2005, 79:9369-9380.
94. Xu J., Lyons P.A., Carter M.D., Booth T.W., Davis-Poynter N.J., Shellam G.R., Scalzo A.A. Assessment of antigenicity and genetic variation of glycoprotein B of murine cytomegalovirus. J. Gen. Virol. 1996, 77:49-59.
95. Yan H., Koyano S., Inami Y., Yamamoto Y., Suzutani T., Mizuguchi M., Ushijima H., Kurane I., Inoue N. Genetic linkage among human cytomegalovirus glycoprotein N (gN) and gO genes, with evidence for recombination from congenitally and post-natally infected Japanese infants. J. Gen. Virol. 2008, 89:2275-2279.